At the same time, the overexpression of NR2F6 appeared to be an efficient indicator in distinguishing hepatoblastoma tissues from non-cancer liver tissues from the indication of summarized AUC of 0.90, with a pooled sensitivity of 0.76 and a pooled specificity of 0.89, demonstrating that overexpressed NR2F6 might act as a promising biomarker in the diagnosis of hepatoblastoma. This evidence concerns the gene NR2F6 and cancer.